Status:
COMPLETED
EMuNI Project: Multiple Nonpharmacological Interventions
Lead Sponsor:
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Collaborating Sponsors:
Ospedale San Raffaele
Istituto Di Ricerche Farmacologiche Mario Negri
Conditions:
Lifestyle Risk Reduction
Eligibility:
All Genders
60-80 years
Phase:
NA
Brief Summary
By 2030, the global prevalence of Alzheimer's Disease (AD) is predicted to reach 65.7 million worldwide. Despite extensive research efforts, a cure for AD has not been identified. Recent studies on no...
Detailed Description
BACKGROUND Recent evidence showed that aerobic exercise, dietary habits and nutritional supplements consumption seem essential for maintaining good cognitive performances increasing hippocampal volume...
Eligibility Criteria
Inclusion
- age between 60 and 80 years;
- presence of memory complaints
Exclusion
- objective cognitive impairment on standard neuropsychological testing;
- history of psychiatric disorders or current clinically relevant depressive or anxious symptoms;
- pacemakers, cochlear implant, metal inserts in the head or shoulders
Key Trial Info
Start Date :
January 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2018
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03382353
Start Date
January 1 2016
End Date
June 1 2018
Last Update
September 14 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Brescia, Italy, 25125
2
Ospedale San Raffaele
Milan, Italy, 20132